{
    "Trade/Device Name(s)": [
        "HemoScreen Hematology Analyzer"
    ],
    "Submitter Information": "PixCell Medical Technologies, Ltd.",
    "510(k) Number": "K240636",
    "Predicate Device Reference 510(k) Number(s)": [
        "K222148"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKZ"
    ],
    "Summary Letter Date": "February 22, 2024",
    "Summary Letter Received Date": "March 6, 2024",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.5220"
    ],
    "Regulation Name(s)": [
        "Automated differential cell counter"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "White blood cells (WBC)",
        "Red blood cells (RBC)",
        "Hemoglobin (HGB)",
        "Hematocrit (HCT)",
        "Mean Corpuscular Volume (MCV)",
        "Mean Cell Hemoglobin (MCH)",
        "Mean Cell Hemoglobin Concentration (MCHC)",
        "Red cell Distribution Width (RDW)",
        "Platelets (PLT)",
        "Mean Platelets Volume (MPV)",
        "Neutrophils (NEUT %/#)",
        "Lymphocytes (LYMP %/#)",
        "Monocytes (MONO %/#)",
        "Eosinophils (EO %/#)",
        "Basophils (BASO %/#)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube",
        "Disposable Sampler with glass capillaries"
    ],
    "Instrument(s)/Platform(s)": [
        "HemoScreen analyzer (reader)"
    ],
    "Method(s)/Technology(ies)": [
        "Microscopic image analysis",
        "Machine vision algorithms",
        "Viscoelastic focusing",
        "Cell staining"
    ],
    "Methodologies": [
        "Automated cell counting",
        "Microscopic image-based classification"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System",
        "Cartridge",
        "Sampler",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemoScreen Hematology Analyzer, an automated tabletop device for CBC and 5-part WBC differential in capillary and venous whole blood.",
    "Indications for Use Summary": "Intended for enumeration and classification of CBC parameters in capillary and venous whole blood (K2EDTA), for in vitro diagnostic use in clinical laboratories and point-of-care settings for adults and children at least 2 years of age.",
    "fda_folder": "Hematology"
}